The sodium glucose co-transporter 2 inhibitor dapagliflozin appears to have therapeutic potential in type 2 diabetes mellitus patients with obstructive sleep apnoea hypopnea syndrome, exerting beneficial effects on apnoea-hypopnea index, hypoxaemia during sleep and daytime sleepiness, as shown in a study.
Obesity is positively associated with moderate-to-severe tooth wear among American adults, with the association partially accounted for by the consumption of sugar-sweetened acidic (SSA) drinks, according to a study.
Regardless of how insulin is delivered, real-time continuous glucose monitoring (rtCGM) outperforms self-monitoring of blood glucose (SMBG) in improving glycaemic control in type 1 diabetes (T1D), according to a recent study.
Patients with nonalcoholic fatty liver disease (NAFLD) tend to consume more energy, macronutrients, added sugar and fructose than the controls, as shown in a Singapore study. Waist circumference and energy consumption, but not fructose intake, significantly correlate with NAFLD.
Treating patients to intensive blood pressure (BP) targets poses an increased risk of impaired fasting glucose, with a small, nonsignificant elevation in the risk of developing diabetes mellitus, as shown in the results of a secondary analysis of SPRINT (Systolic Blood Pressure Intervention Trial).
The risk of acute kidney injury (AKI) appears to be lower among patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter-2 inhibitors (SGLT2is), suggest the results of a systematic review and meta-analysis.
Greater parity, early age at menarche, or oral contraceptive use may increase a woman’s risk of undergoing total knee replacement (TKR) for severe knee osteoarthritis (OA), according to findings from the Singapore Chinese Health Study (SCHS).